Bank of America, Royal Bank of Canada, and Truist Financial raised price targets for Agios Pharmaceuticals on July 31, 2026.
2 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America, Royal Bank of Canada, and Truist Financial raised price targets for Agios Pharmaceuticals on July 31, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Agios Pharmaceuticals
a public American pharmaceutical company